Atrial leadless pacing is feasible in a 32-year-old male with lateral tunnel Fontan, achieving 98% atrial pacing at 4 months without intracardiac thrombus.
Is atrial leadless pacing feasible and safe in a patient with a lateral tunnel Fontan and symptomatic bradycardia?
n=1, 32-year-old male with tricuspid atresia status post Blalock-Taussig shunt, Glenn procedure, and Fontan surgery at 5 years of age, presenting with symptomatic bradycardia in the setting of sinus node dysfunction and epicardial lead fracture.
Atrial leadless pacemaker (Aveir VR) implanted in the septal aspect of the lateral tunnel Fontan, programmed AAIR (VVIR) 80-130 bpm, and discharged on apixaban 5 mg twice a day.
Feasibility of implantation and device electrical parameters (threshold, impedance, sensing) at follow-up.
Atrial leadless pacing is feasible and demonstrates stable short-term parameters in a patient with a lateral tunnel Fontan and sinus node dysfunction.
ABSTRACT Introduction No reports on atrial leadless pacing have been demonstrated in patients with the Fontan palliation. We present the case of a patient with a Lateral tunnel Fontan palliation with leadless pacing system for symptomatic bradycardia in the setting of sinus node dysfunction. Methods After internal review board approval, a retrospective case review was performed with follow‐up of atrial leadless pacing in a patient with a Lateral tunnel Fontan. Results A 32‐year‐old male with a medical history of tricuspid atresia status post: Blalock‐Taussig Shunt (BT) shunt, Glenn procedure, and Fontan surgery at 5 years of age presented with persistent atrial flutter and a history of symptomatic heart failure in the setting sick sinus syndrome with a dual chamber epicardial pacemaker procedure. After ablation of his intra‐atrial re‐entrant tachycardia he continued with symptomatic bradycardia in the setting of epicardial lead fracture. Implant values demonstrated an atrial threshold of 1 Volts (V) at 0.4 ms (ms), impedance at 820 ohms and sensing at < 1 mV. He was programmed AAIR (VVIR) 80–130 bpm, rate response of 2/7, and discharged on apixaban 5 mg twice a day. Follow‐up at 4 months demonstrated no intracardiac thrombus, 98% atrial pacing, threshold of 0.75 V@0.15 ms, impedance of 590 ohms, and R‐wave of 2.5 mV. The estimated device longevity was 17.2 years. Conclusion Atrial leadless pacing is feasible in the lateral tunnel Fontan. Larger patient population data sets are needed to assess safety of this type of pacing long‐term.
Building similarity graph...
Analyzing shared references across papers
Loading...
Daniel Cortez
Omar Abu Anza
Mohammad Alnoor
Journal of Cardiovascular Electrophysiology
University of California, Davis
Building similarity graph...
Analyzing shared references across papers
Loading...
Cortez et al. (Fri,) reported a other. Atrial leadless pacing is feasible in a 32-year-old male with lateral tunnel Fontan, achieving 98% atrial pacing at 4 months without intracardiac thrombus.
www.synapsesocial.com/papers/696c79cde45ebfc9113cd40d — DOI: https://doi.org/10.1111/jce.70215